Marco Gasparetto

ORCID: 0000-0002-3882-3606
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Eosinophilic Esophagitis
  • Gastrointestinal disorders and treatments
  • Pediatric Hepatobiliary Diseases and Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Helicobacter pylori-related gastroenterology studies
  • Adolescent and Pediatric Healthcare
  • Gastroesophageal reflux and treatments
  • Celiac Disease Research and Management
  • Digestive system and related health
  • Liver Diseases and Immunity
  • Autoimmune and Inflammatory Disorders Research
  • Infant Nutrition and Health
  • Gallbladder and Bile Duct Disorders
  • Pharmaceutical studies and practices
  • Intestinal Malrotation and Obstruction Disorders
  • Pregnancy and Medication Impact
  • Congenital Anomalies and Fetal Surgery
  • Intestinal and Peritoneal Adhesions
  • Autoimmune and Inflammatory Disorders
  • Gastrointestinal motility and disorders
  • Tuberculosis Research and Epidemiology
  • IL-33, ST2, and ILC Pathways
  • Congenital gastrointestinal and neural anomalies

Norfolk and Norwich University Hospital
2023-2025

University of East Anglia
2023-2025

Barts Health NHS Trust
2020-2024

Queen Mary University of London
2022-2024

Ospedale Sant'Anna
2023

Royal London Hospital
2021-2022

Brunel University of London
2022

Addenbrooke's Hospital
2014-2021

Cambridge University Hospitals NHS Foundation Trust
2014-2021

University of Cambridge
2014-2020

We analyzed DNA methylation patterns and transcriptomes of primary intestinal epithelial cells (IEC) children newly diagnosed with inflammatory bowel diseases (IBD) to learn more about pathogenesis.We obtained mucosal biopsies (N = 236) collected from terminal ileum ascending sigmoid colons (median age 13 years) IBD (43 Crohn's disease [CD], 23 ulcerative colitis [UC]), 30 without (controls). Patients were recruited managed at a hospital in the United Kingdom 2013 through 2016. also later...

10.1053/j.gastro.2017.10.007 article EN cc-by Gastroenterology 2017-10-12
Katharina Werkstetter Ilma R. Korponay–Szabó Alina Popp Vincenzo Villanacci Marianna Salemme and 95 more G.H.J. Heilig Søren Thue Lillevang M. Luisa Mearin Carmen Ribes‐Koninckx Adrian G. Thomas Riccardo Troncone Birgit Filipiak Markku Mäki Judit Gyimesi Mehri Najafi Jernej Dolinšek Stine Dydensborg Sander Renata Auricchio Alexandra Papadopoulou Andreas Vécsei Peter Szitányi Ester Donat Raffaella Nenna Philippe Alliët Francesca Penagini Hélène Garnier‐Lengliné Gemma Castillejo Kalle Kurppa Raanan Shamir Almuthe Hauer Françoise Smets Susana Corujeira Myriam Van Winckel Stephan Buderus Sonny K. F. Chong Steffen Husby Sibylle Koletzko Piotr Socha Božena Cukrowská Hania Szajewska J Wyhowski Nailah Brown Gauri Batra Zrinjka Mišak Sven Seiwerth Yulia Dmitrieva Д. С. Абрамов Yvan Vandenplas Annieta Goossens Maaike W. Schaart Vincent T.H.B.M. Smit Nicolas Kalach Philippe Gosset Judit B. Kovács Anikó Nagy Ilona Lellei Rita Kőbányai Katayoun Khatami Maryam Monajemzadeh K. Dimakou Amalia Patereli Tine Plato Hansen Rajko Kavalar Miguel Bolonio David Ramos Hubert Kogler Gabriele Amann Roberta Kosova Mariantonia Maglio Elke Janssens Ruth Achten Pavel Frühauf Helena Skálová Thomas Kirchner Laura Petrarca Fabio Massimo Magliocca F. Rocuts Martinez Vanesa Morente Sonja Thanner-Lechner Manfred Ratschek Marco Gasparetto Liz Hook Danielle Canioni Catherine Wanty Anne Mourin Kaija Laurila Martine Vornane Vered Nachmias Friedler Sara Morgenstern Jorge Amil Dias Fátima Carneiro Hospital S. João Stéphanie Van Biervliet Saskia Vande Velde Hany Banoub Steve Sampson Annette Müller Adina Ene Mandana Rafeey Amir Taher Eftekhar Sadat

10.1053/j.gastro.2017.06.002 article EN Gastroenterology 2017-06-16

Inflammatory bowel disease [IBD] presenting in early childhood is extremely rare. More recently, progress has been made to identify children with monogenic forms of IBD predominantly very life. In this study, we describe the heterogeneous phenotypes and genotypes patients before age 2 years establish phenotypic features associated underlying monogenicity.Phenotype data 62 onset over past 20 were reviewed. Children without previously established genetic diagnosis prospectively recruited for...

10.1093/ecco-jcc/jjw118 article EN Journal of Crohn s and Colitis 2016-06-14

Early-onset (EO) pediatric inflammatory bowel diseases (IBD) seem to be more extensive than those with a later onset. To test this hypothesis, we examined the phenotype and disease course of patients IBD diagnosis at 0 5 years, compared ranges 6 11 12 18 years.Anatomic locations behaviors were assessed according Paris classification in 506 consecutive patients: 224 Crohn's disease, 245 ulcerative colitis, 37 IBD-unclassified.Eleven percent range 39% 50% years. Ulcerative colitis was most...

10.1097/01.mib.0000442921.77945.09 article EN Inflammatory Bowel Diseases 2014-02-25

Objective Epigenetic mechanisms, including DNA methylation (DNAm), have been proposed to play a key role in Crohn’s disease (CD) pathogenesis. However, the specific cell types and pathways affected as well their potential impact on phenotype outcome remain unknown. We set out investigate of intestinal epithelial DNAm CD Design generated 312 organoids (IEOs) from mucosal biopsies 168 patients with (n=72), UC (n=23) healthy controls (n=73). performed genome-wide molecular profiling DNAm, bulk...

10.1136/gutjnl-2024-332043 article EN cc-by-nc Gut 2024-06-10

There are scarce data available on upadacitinib in children with Crohn's disease (CD). To evaluate the effectiveness and safety of as an induction therapy paediatric CD. This was a multicentre retrospective study between 2022 2024 treated for remission active CD conducted 30 centres worldwide affiliated IBD Interest Porto group ESPGHAN. We recorded demographic, clinical laboratory adverse events (AEs) at week 8 post-induction. The analysis primary outcome based upon intention-to-treat (ITT)...

10.1111/apt.70016 article EN cc-by-nc-nd Alimentary Pharmacology & Therapeutics 2025-02-08

ABSTRACT Background and Objective: In recent decades, there has been a significant increase in the incidence of inflammatory bowel disease (IBD). It yet to be established whether manifestations IBD are similar paediatric adult ages. The objective this study was compare phenotypic expression between patients with childhood‐onset adulthood‐onset cases, all afferent same clinical centre. Patients Methods: Descriptive multivariate analyses were completed on retrospective prospective data...

10.1097/mpg.0b013e3181da1db8 article EN Journal of Pediatric Gastroenterology and Nutrition 2010-07-16

DNA methylation is one of the major epigenetic mechanisms implicated in regulating cellular development and cell-type-specific gene expression. Here we performed simultaneous genome-wide expression analysis on purified intestinal epithelial cells derived from human fetal gut, healthy pediatric biopsies, children newly diagnosed with inflammatory bowel disease (IBD). Results were validated using pyrosequencing, real-time PCR, immunostaining. The functional impact changes was assessed by...

10.1038/mi.2015.88 article EN cc-by-nc-nd Mucosal Immunology 2015-09-16

Abstract Background Data on upadacitinib therapy in children with ulcerative colitis (UC) or unclassified inflammatory bowel disease (IBD-U) are scarce. We aimed to evaluate the effectiveness and safety of as an induction pediatric UC IBD-U. Methods In this multicenter retrospective study, treated for remission active IBD-U from 30 centers worldwide were enrolled. Demographic, clinical laboratory data well adverse events (AEs) recorded at week 8 post induction. Results One hundred included...

10.1093/ecco-jcc/jjae190.0090 article EN Journal of Crohn s and Colitis 2025-01-01

Abstract Background Data on upadacitinib therapy in children with Crohn’s disease (CD) are scarce. We aimed to evaluate the effectiveness and safety of as an induction pediatric CD. Methods A multicenter retrospective study treated for remission active CD from 30 centers worldwide affiliated IBD Interest Porto group ESPGHAN between 2022 2024. Demographic, clinical, laboratory, imaging data well adverse events (AEs) were recorded at week 8 post induction. The analysis primary outcome was...

10.1093/ecco-jcc/jjae190.0094 article EN Journal of Crohn s and Colitis 2025-01-01

Background . Though Helicobacter pylori (HP) infections have progressively declined throughout most of the industrialized countries, a gradual increase in failure HP eradication treatments is observed. Aim To critically review evidence on efficacy therapeutic availabilities for eradication, as yet. Methods A selection Clinical Trials, Systematic Reviews and Meta-analyses within time period 2010–2012, was performed through Medline search. Previous references were included when basically...

10.5402/2012/186734 article EN ISRN Gastroenterology 2012-07-29

Most children with Inflammatory Bowel Disease (IBD) are diagnosed between 11 and 16 years of age, commonly presenting features typical IBD. Children onset gut inflammation under 5 age often have a different underlying pathophysiology, one that is genetically phenotypically distinct from other We therefore set out to assess whether after the years, but before 11, clinical presentation outcome when compared those later.Retrospective cohort study conducted at two European Paediatric...

10.1186/s12876-016-0455-y article EN cc-by BMC Gastroenterology 2016-03-15

Faecal calprotectin (FCP) is a powerful tool to predict inflammatory bowel disease (IBD) in patients with gastrointestinal symptoms. In the paediatric patient population, reference value of < 50 μg/g and influence age on FCP levels result high number redundant investigations specialist referrals. We assessed levels, their diagnostic corresponding referral pathways from primary secondary care.We analysed two cohorts precisely defined catchment area: one consisted all FCPs measured this area...

10.1371/journal.pone.0246091 article EN cc-by PLoS ONE 2021-02-11

Whether primary sclerosing cholangitis related to inflammatory bowel disease (PSC-IBD) diagnosed before 6 years (ie, VEO-IBD) has a distinct phenotype and course is uninvestigated. We aimed analyze the characteristics natural history of VEO-PSC-IBD, compared with early adolescent-onset PSC-IBD.

10.1093/ibd/izad218 article EN Inflammatory Bowel Diseases 2023-09-28

Background . Peptic ulcer disease (PUD) in children is reported worldwide, although it relatively rare as compared with adults. Helicobacter pylori (HP) infection a common cause of PUD the pediatric age. Other risk factors include use nonsteroidal anti-inflammatory agents (NSAIDs), steroids, immunosuppressive drugs, and stressful events. Aim To critically review evidence on epidemiology, diagnostic management, available treatments for Methods. A MEDLINE search was performed indicating...

10.1155/2012/896509 article EN cc-by Ulcers 2012-11-05
Coming Soon ...